| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kyung-Jun Boo, Dae Hyun Kim, Eunbi Cho, Dong Hyun Kim, Se Jin Jeon, Chan Young Shi. Neonatal dysregulation of 2-arachidonoylglycerol induces impaired brain function in adult mice. Neuropharmacology. 2024-06-17. PMID:38885736. |
the endocannabinoid system (ecs) regulates neurotransmission linked to synaptic plasticity, cognition, and emotion. |
2024-06-17 |
2024-06-21 |
mouse |
| R S Rodrigues, J B Moreira, J M Mateus, A Barateiro, S L Paulo, S H Vaz, D M Lourenço, F F Ribeiro, R Soares, E Loureiro-Campos, P Bielefeld, A M Sebastião, A Fernandes, L Pinto, C P Fitzsimons, S Xapell. Cannabinoid type 2 receptor inhibition enhances the antidepressant and proneurogenic effects of physical exercise after chronic stress. Translational psychiatry. vol 14. issue 1. 2024-03-30. PMID:38555299. |
recent data sheds light on the interaction between cannabinoids and neurotrophic factors underlying the regulation of ahn, with important effects on cognitive plasticity and emotional flexibility. |
2024-03-30 |
2024-04-02 |
Not clear |
| Subir Gupta, Ambadasu Bharatha, Damian Cohall, Sayeeda Rahman, Mainul Haque, Md Anwarul Azim Majumde. Aerobic Exercise and Endocannabinoids: A Narrative Review of Stress Regulation and Brain Reward Systems. Cureus. vol 16. issue 3. 2024-03-05. PMID:38440201. |
the endocannabinoid has been observed to govern the release of neurotransmitters from diverse neuronal populations, implying a universal mechanism that fine-tunes neuronal activity and consequently modulates both emotional and stress-related responses. |
2024-03-05 |
2024-03-07 |
Not clear |
| Jonasz Dragon, Ewa Obuchowic. How depression and antidepressant drugs affect endocannabinoid system?-review of clinical and preclinical studies. Naunyn-Schmiedeberg's archives of pharmacology. 2024-01-27. PMID:38280009. |
one of them is endocannabinoid system, which has been proposed as a manager of emotional homeostasis, and thus, endocannabinoid alterations have been found in animals undergoing various preclinical models of depression procedures as well as in humans suffering from depressive-like disorders. |
2024-01-27 |
2024-01-30 |
Not clear |
| Wen-Hao Liu, Jun-Shang Wu, Li-Bo Hua, Zhi-Feng Pan, Hai-Bo Zhang, Neng-Gui Xu, Yi-Han H. Advances in the study of endocannabinoid receptors in experimental acupuncture analgesia. Zhen ci yan jiu = Acupuncture research. vol 49. issue 1. 2024-01-19. PMID:38239143. |
the endocannabinoid system, an important biological network for maintaining and balancing various functions of the human body, is involved in many physiological functions such as pain, emotion, learning and memory, etc. |
2024-01-19 |
2024-01-21 |
human |
| Laura Rullo, Loredana Maria Losapio, Camilla Morosini, Francesca Mottarlini, Sara Schiavi, Valeria Buzzelli, Fabrizio Ascone, Roberto Ciccocioppo, Liana Fattore, Lucia Caffino, Fabio Fumagalli, Patrizia Romualdi, Viviana Trezza, Sanzio Candelett. Outcomes of early social experiences on glucocorticoid and endocannabinoid systems in the prefrontal cortex of male and female adolescent rats. Frontiers in cellular neuroscience. vol 17. 2024-01-04. PMID:38174157. |
in this scenario, the present study was aimed at (i) investigating the impact of early social environments on emotional reactivity of adolescent male and female rats and (ii) uncovering the underlying molecular features, focusing on the cortical endocannabinoid (ecb) and glucocorticoid systems. |
2024-01-04 |
2024-01-06 |
rat |
| Eduardo J Fusse, Franciele F Scarante, Maria A Vicente, Mariana M Marrubia, Flávia Turcato, Davi S Scomparin, Melissa A Ribeiro, Maria J Figueiredo, Tamires A V Brigante, Francisco S Guimarães, Alline C Campo. Anxiogenic doses of rapamycin prevent URB597-induced anti-stress effects in socially defeated mice. Neuroscience letters. vol 818. 2023-11-01. PMID:37852528. |
repeated exposure to psychosocial stress modulates the endocannabinoid system, particularly anandamide (aea) signaling in brain regions associated with emotional distress. |
2023-11-01 |
2023-11-08 |
mouse |
| Matthew N Hill, Margaret Haney, Cecilia J Hillard, Debra S Karhson, Haley A Vecchiarell. The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses. Psychological medicine. 2023-09-06. PMID:37671673. |
cannabis is well established to impact affective states, emotion and perceptual processing, primarily through its interactions with the endocannabinoid system. |
2023-09-06 |
2023-10-07 |
Not clear |
| Jun-Fan Xie, Lin-Xin Wang, Wen-Ting Ren, Can Wang, Jin-Xian Gao, Hai-Lin Chen, Xue-Qi Zhao, Yan-Li Ren, Yu-Ping Xie, Yu-Feng Shao, Yi-Ping Ho. An α-hemoglobin-derived peptide (m)VD-hemopressin (α) promotes NREM sleep via the CB Frontiers in pharmacology. vol 14. 2023-07-17. PMID:37456761. |
the previous studies demonstrated that the endocannabinoid system played important roles in modulating several physiological functions such as sleep, olfaction, emotion, learning and memory, and reward behaviors. |
2023-07-17 |
2023-08-14 |
mouse |
| Lin Zhu, Di Zheng, Rui Li, Chen-Jie Shen, Ruolan Cai, Chenfei Lyu, Binliang Tang, Hao Sun, Xiaohui Wang, Yu Ding, Bin Xu, Guoqiang Jia, Xinjian Li, Lixia Gao, Xiao-Ming L. Induction of Anxiety-Like Phenotypes by Knockdown of Cannabinoid Type-1 Receptors in the Amygdala of Marmosets. Neuroscience bulletin. 2023-06-27. PMID:37368194. |
meanwhile, the endocannabinoid system plays a crucial role in regulating emotions and mainly functions through the cannabinoid type-1 receptor (cb |
2023-06-27 |
2023-08-14 |
Not clear |
| Giordano Novak Rossi, Juliana Mendes Rocha, Flávia L Osório, José Carlos Bouso, Genis Ona, Gabriela de Oliveira Silveira, Mauricio Yonamine, Giuliana Bertozi, Eduardo José Crevelin, Maria Eugênia Queiroz, José Alexandre S Crippa, Jaime E Cecílio Hallak, Rafael G Dos Santo. Interactive Effects of Ayahuasca and Cannabidiol in Social Cognition in Healthy Volunteers: A Pilot, Proof-of-Concept, Feasibility, Randomized-Controlled Trial. Journal of clinical psychopharmacology. 2023-06-19. PMID:37335211. |
serotonergic hallucinogens and cannabinoids may alter the recognition of emotions in facial expressions (refe). |
2023-06-19 |
2023-08-14 |
human |
| Małgorzata Frankowska, Karolina Wydra, Agata Suder, Magdalena Zaniewska, Dawid Gawliński, Joanna Miszkiel, Anna Furgała-Wojas, Kinga Sałat, Małgorzata Filip, Christa E Müller, Katarzyna Kieć-Kononowicz, Magdalena Kotańsk. Novel GPR18 Ligands in Rodent Pharmacological Tests: Effects on Mood, Pain, and Eating Disorders. International journal of molecular sciences. vol 24. issue 10. 2023-05-27. PMID:37240392. |
we investigated these ligands in several screening tests, considering the relationship between gpr18 and the cannabinoid (cb) receptor system, and the control of endocb signaling over emotions, food intake, pain sensation, and thermoregulation. |
2023-05-27 |
2023-08-14 |
Not clear |
| Anna Marie Balestra, Katharina Chalk, Claudia Denke, Nashwan Mohammed, Thomas Fritzsche, Sascha Tafelsk. Influence of Cannabinoid Treatment on Trajectories of Patient-Related Outcomes in Chronic Pain: Pain Intensity, Emotional Distress, Tolerability and Physical Disability. Brain sciences. vol 13. issue 4. 2023-05-16. PMID:37190645. |
influence of cannabinoid treatment on trajectories of patient-related outcomes in chronic pain: pain intensity, emotional distress, tolerability and physical disability. |
2023-05-16 |
2023-08-14 |
Not clear |
| Anna Marie Balestra, Katharina Chalk, Claudia Denke, Nashwan Mohammed, Thomas Fritzsche, Sascha Tafelsk. Influence of Cannabinoid Treatment on Trajectories of Patient-Related Outcomes in Chronic Pain: Pain Intensity, Emotional Distress, Tolerability and Physical Disability. Brain sciences. vol 13. issue 4. 2023-05-16. PMID:37190645. |
the present study shows that pain intensity (mean relative reduction (-14.9 ± 22.6%), emotional distress (-9.2 ± 43.5%), pain-associated disability (-7.0 ± 46.5%) and tolerability of pain (-11 ± 23.4%)) improved with cannabinoid treatment. |
2023-05-16 |
2023-08-14 |
Not clear |
| Irene Perini, Leah M Mayo, Andrea J Capusan, Elisabeth R Paul, Adam Yngve, Robin Kampe, Emelie Gauffin, Raegan Mazurka, Bijar Ghafouri, Niclas Stensson, Anna Asratian, J Paul Hamilton, Åsa Kastbom, Per A Gustafsson, Markus Heili. Resilience to substance use disorder following childhood maltreatment: association with peripheral biomarkers of endocannabinoid function and neural indices of emotion regulation. Molecular psychiatry. 2023-04-11. PMID:37041416. |
resilience to substance use disorder following childhood maltreatment: association with peripheral biomarkers of endocannabinoid function and neural indices of emotion regulation. |
2023-04-11 |
2023-08-14 |
human |
| Irene Perini, Leah M Mayo, Andrea J Capusan, Elisabeth R Paul, Adam Yngve, Robin Kampe, Emelie Gauffin, Raegan Mazurka, Bijar Ghafouri, Niclas Stensson, Anna Asratian, J Paul Hamilton, Åsa Kastbom, Per A Gustafsson, Markus Heili. Resilience to substance use disorder following childhood maltreatment: association with peripheral biomarkers of endocannabinoid function and neural indices of emotion regulation. Molecular psychiatry. 2023-04-11. PMID:37041416. |
this case-control study investigated the impact of prospectively assessed cm on biomarkers of endocannabinoid function and emotion regulation in relation to the susceptibility or resilience to developing sud. |
2023-04-11 |
2023-08-14 |
human |
| Arijana Demaili, Anna Portugalov, Michal Dudai, Mouna Maroun, Irit Akirav, Katharina Braun, Jörg Boc. Epigenetic (re)programming of gene expression changes of CB1R and FAAH in the medial prefrontal cortex in response to early life and adolescence stress exposure. Frontiers in cellular neuroscience. vol 17. 2023-03-13. PMID:36909279. |
the endocannabinoid system plays a major role in the regulation of stress responses and emotional behavior, thereby acting as a mediator of stress vulnerability and resilience. |
2023-03-13 |
2023-08-14 |
rat |
| Marialuisa de Ceglia, Maria Vittoria Micioni Di Bonaventura, Adele Romano, Marzia Friuli, Emanuela Micioni Di Bonaventura, Ana L Gavito, Luca Botticelli, Silvana Gaetani, Fernando Rodríguez de Fonseca, Carlo Cifan. Anxiety associated with palatable food withdrawal is reversed by the selective FAAH inhibitor PF-3845: A regional analysis of the contribution of endocannabinoid signaling machinery. The International journal of eating disorders. 2023-02-25. PMID:36840536. |
currently, no pharmacological treatment is effective for obesity-related anxiety, so we investigated the endocannabinoid system (ecs), and specifically the fatty acid amide hydrolase (faah), as an interesting emerging target in this context because of its key role in the regulation of both energy homeostasis and emotional behavior. |
2023-02-25 |
2023-08-14 |
Not clear |
| Daniela Matei, Dan Trofin, Daniel Andrei Iordan, Ilie Onu, Iustina Condurache, Catalin Ionite, Ioana Bucule. The Endocannabinoid System and Physical Exercise. International journal of molecular sciences. vol 24. issue 3. 2023-02-11. PMID:36768332. |
the endocannabinoid system (ecs) is involved in various processes, including brain plasticity, learning and memory, neuronal development, nociception, inflammation, appetite regulation, digestion, metabolism, energy balance, motility, and regulation of stress and emotions. |
2023-02-11 |
2023-08-14 |
human |
| Roberto Colangeli, Maria Morena, Allison Werner, Roger J Thompson, Mario van der Stelt, Quentin J Pittman, Matthew N Hill, G Campbell Teske. 2-AG-mediated Control of GABAergic Signaling is Impaired in a Model of Epilepsy. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2022-12-02. PMID:36460464. |
repeated seizures result in a persistent maladaptation of endocannabinoid signaling, mediated in part by anandamide signaling deficiency in the basolateral amygdala (bla) that manifests as aberrant synaptic function and altered emotional behaviour. |
2022-12-02 |
2023-08-14 |
Not clear |